BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6466536)

  • 21. Second-look laparotomy in managing epithelial ovarian carcinoma.
    Dauplat J; Ferriere JP; Gorbinet M; Legros M; Chollet P; Giraud B; Plagne R
    Cancer; 1986 Apr; 57(8):1627-31. PubMed ID: 3948133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Second-look laparotomy in the management of malignant germ cell tumors of the ovary.
    Gershenson DM; Copeland LJ; del Junco G; Edwards CL; Wharton JT; Rutledge FN
    Obstet Gynecol; 1986 Jun; 67(6):789-93. PubMed ID: 3010204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The value of cytoreductive second-look surgery in advanced epithelial ovarian carcinoma].
    Sevelda P; Barrada M; Vavra N; Denison U; Schmidl S; Genger H; Salzer H
    Wien Klin Wochenschr; 1990 Aug; 102(15):441-3. PubMed ID: 2402929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Second-look laparotomy for ovarian cancer provides reliable prognostic information and improves survival.
    Friedman RL; Eisenkop SM; Wang HJ
    Gynecol Oncol; 1997 Oct; 67(1):88-94. PubMed ID: 9345362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival of women with advanced ovarian cancer and complete pathologic response at second-look laparotomy.
    Bolis G; Villa A; Guarnerio P; Ferraris C; Gavoni N; Giardina G; Melpignano M; Scarfone G; Zanaboni F; Parazzini F
    Cancer; 1996 Jan; 77(1):128-31. PubMed ID: 8630918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors for outcome of and survival after second-look laparotomy in patients with advanced ovarian carcinoma.
    Lund B; Williamson P
    Obstet Gynecol; 1990 Oct; 76(4):617-22. PubMed ID: 2216190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advanced ovarian cancer: long-term results following chemotherapy and second-look laparotomy.
    Davidson NG; Khanna S; Kirwan P; Bircumshaw D
    Gynecol Oncol; 1990 Dec; 39(3):295-9. PubMed ID: 2258074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cisplatin and cyclophosphamide in early epithelial ovarian carcinoma.
    Chiara S; Conte PF; Bruzzone M; Falcone A; Sertoli MR; Carnino F; Mossetti C; Iura R; Durando C; Guercio E
    Chemioterapia; 1987 Oct; 6(5):380-3. PubMed ID: 3427698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Second-look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease status.
    Berek JS; Hacker NF; Lagasse LD; Poth T; Resnick B; Nieberg RK
    Obstet Gynecol; 1984 Aug; 64(2):207-12. PubMed ID: 6539884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.
    Petit T; Velten M; d'Hombres A; Marchal C; Montbarbon X; Mornex F; Quetin P; Gérard JP; Romestaing P; Carrie C
    Gynecol Oncol; 2007 Jan; 104(1):104-8. PubMed ID: 16987544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Second-look laparotomy.
    Moore JL; Barter JF
    Semin Surg Oncol; 1994; 10(4):276-82. PubMed ID: 8091069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Second-look laparotomy for ovarian carcinoma.
    Copeland LJ
    Clin Obstet Gynecol; 1985 Dec; 28(4):816-23. PubMed ID: 4075633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma.
    Louie KG; Ozols RF; Myers CE; Ostchega Y; Jenkins J; Howser D; Young RC
    J Clin Oncol; 1986 Nov; 4(11):1579-85. PubMed ID: 3095501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term survival in advanced ovarian cancer after cytoreduction and chemotherapy treatment.
    Del Campo JM; Felip E; Rubio D; Vidal R; Bermejo B; Colomer R; Zanon V
    Gynecol Oncol; 1994 Apr; 53(1):27-32. PubMed ID: 8175018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of epithelial cancers of the ovary in advanced stages with surgery and cisplatin chemotherapy].
    Dauplat J; Ferrière JP; Gorbinet M; Legros M; Chollet P; Giraud B; Plagne R
    Presse Med; 1986 Sep; 15(29):1351-4. PubMed ID: 2950408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polychemotherapy and second-look laparotomy in the management of the ovarian cancer.
    Draca P
    Eur J Gynaecol Oncol; 1988; 9(5):410-4. PubMed ID: 3224611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second-look laparotomy in endodermal sinus tumor: a report of two patients with normal levels of alpha-fetoprotein and residual tumor at reexploration.
    Curtin JP; Rubin SC; Hoskins WJ; Hakes TB; Lewis JL
    Obstet Gynecol; 1989 May; 73(5 Pt 2):893-5. PubMed ID: 2468119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hexamethylmelamine, cyclophosphamide, adriamycin, cis-platinum chemotherapy as initial and second-line treatment of advanced ovarian carcinoma.
    Richman CM; Podczaski E; Weiser PA; Herbst AL
    Oncology; 1986; 43(1):12-7. PubMed ID: 3079898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Second-look laparotomy in epithelial ovarian cancer: an evaluation of 23 cases].
    Liu LY
    Zhonghua Fu Chan Ke Za Zhi; 1990 Mar; 25(2):77-9, 123. PubMed ID: 2364794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of cytoreductive surgery in advanced carcinoma of the ovary: an analysis of primary and second surgery.
    Wiltshaw E; Raju KS; Dawson I
    Br J Obstet Gynaecol; 1985 May; 92(5):522-7. PubMed ID: 3994934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.